S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NXL Nexalin Technologies Inc

1.28

0.00 (0.00%)

Pre Market

Last Updated: 06:00:01

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Nexalin Technologies (NASDAQ:NXL)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Nexalin Technologies Charts.

Nexalin Technologies (NASDAQ:NXL)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Nexalin Technologies Charts.

Nexalin Technologies Inc News

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23
Thursday 9 May 2024 (4 days ago) • GlobeNewswire Inc.

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
Thursday 25 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing
Tuesday 9 April 2024 (1 month ago) • GlobeNewswire Inc.

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
Thursday 4 April 2024 (1 month ago) • GlobeNewswire Inc.

Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
Thursday 28 March 2024 (2 months ago) • GlobeNewswire Inc.

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
Thursday 8 February 2024 (3 months ago) • GlobeNewswire Inc.

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System
Tuesday 23 January 2024 (4 months ago) • GlobeNewswire Inc.

Nexalin Technology Unveils Next-Generation HALO™ Clarity
Thursday 11 January 2024 (4 months ago) • GlobeNewswire Inc.

Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression
Monday 18 December 2023 (5 months ago) • GlobeNewswire Inc.

More Nexalin Technologies Inc News Articles

Deka Iboxx Eur Liq Ger C...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions